Sale!

Chikungunya RNA Detection Qualitative Test Cost

Original price was: 600 د.إ.Current price is: 510 د.إ.

-15%

The “Chikungunya RNA Detection Qualitative Test” is a diagnostic procedure performed to identify the presence of Chikungunya virus RNA in a patient’s sample, usually blood. This test is crucial for the accurate diagnosis of Chikungunya fever, a viral disease transmitted by mosquitoes, which causes symptoms such as fever, joint pain, headache, nausea, fatigue, and rash. The qualitative nature of the test means it is designed to indicate whether the virus’s RNA is present or not, rather than measuring the amount of virus.

Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and stringent quality controls, this test offers reliable results. The cost of the test is set at 510 AED, which reflects the sophisticated methods used, such as real-time polymerase chain reaction (RT-PCR), to detect the viral RNA with high sensitivity and specificity. This test is essential for healthcare providers to make informed decisions about patient care and to implement appropriate treatment strategies for those affected by Chikungunya virus.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Chikungunya RNA Detection Qualitative Test

Cost: 510.0 AED

Test Details

A Chikungunya RNA Detection Qualitative Test is a diagnostic tool used to detect the presence of Chikungunya virus RNA in a patient’s blood sample. Chikungunya is a viral disease transmitted to humans through the bite of infected Aedes mosquitoes.

Components

Price: 510.0 AED

Sample Condition

Serum, plasma, whole blood

Report Delivery

3rd Working Day Email: 36 hours
On phone: 24 hours

Method

Real Time PCR

Test Type

Viral

Doctor

Physician

Test Department

Genetics

Pre Test Information

Need to sign Consent document and bring any clinical history of patient for Chikungunya (RNA Detection) Qualitative Test

Test Procedure

The Chikungunya RNA Detection Qualitative Test works by using a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect specific regions of the Chikungunya virus RNA. The RNA is first converted into complementary DNA (cDNA) using reverse transcriptase enzyme. Then, the cDNA is amplified using PCR to produce multiple copies of the target viral RNA sequence. The test uses specific primers and probes that bind to the Chikungunya virus RNA sequence of interest. If the virus is present in the patient’s blood sample, the primers and probes will bind to the viral RNA, and the PCR amplification will produce a fluorescent signal. The presence of the fluorescent signal indicates a positive result, indicating the presence of Chikungunya virus in the patient’s blood.

Advantages of the Test

The Chikungunya RNA Detection Qualitative Test is highly sensitive and specific, allowing for early and accurate diagnosis of Chikungunya infection. It can be used in the early stages of infection, even before the onset of symptoms, enabling prompt treatment and appropriate public health measures to prevent the spread of the virus.

Limitations

It is important to note that this test only detects the presence of viral RNA and does not indicate the severity of the infection or the presence of antibodies. Additional tests may be required to assess the immune response and monitor the progression of the disease.

Test Name Chikungunya RNA Detection Qualitative Test
Components
Price 510.0 AED
Sample Condition Serum, plasma, whole blood
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forChikungunya (RNA Detection) QualitativeTest
Test Details

A Chikungunya RNA Detection Qualitative Test is a diagnostic tool used to detect the presence of Chikungunya virus RNA in a patient’s blood sample. Chikungunya is a viral disease transmitted to humans through the bite of infected Aedes mosquitoes.

The test works by using a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect specific regions of the Chikungunya virus RNA. The RNA is first converted into complementary DNA (cDNA) using reverse transcriptase enzyme. Then, the cDNA is amplified using PCR to produce multiple copies of the target viral RNA sequence.

The test uses specific primers and probes that bind to the Chikungunya virus RNA sequence of interest. If the virus is present in the patient’s blood sample, the primers and probes will bind to the viral RNA, and the PCR amplification will produce a fluorescent signal. The presence of the fluorescent signal indicates a positive result, indicating the presence of Chikungunya virus in the patient’s blood.

The Chikungunya RNA Detection Qualitative Test is highly sensitive and specific, allowing for early and accurate diagnosis of Chikungunya infection. It can be used in the early stages of infection, even before the onset of symptoms, enabling prompt treatment and appropriate public health measures to prevent the spread of the virus.

It is important to note that this test only detects the presence of viral RNA and does not indicate the severity of the infection or the presence of antibodies. Additional tests may be required to assess the immune response and monitor the progression of the disease.